National News Coverage for MediSieve

National News Coverage for MediSieve
Created on 13-11-2019

Founder and CEO, Dr George Frodsham, speaks to the Telegraph on the birth and journey of MediSieve.

You may have seen us featured in the Telegraph on Sunday 10 November.

Here, Dr Frodsham, divulges how he came up with the idea while studying how magnetic nanoparticles can be made to bind to cells in the body, to allow, for example those cells to show up on scanners.

Read the full article here.

We were also fortunate enough to have this article featured in The Mirror.

Sort by:

Latest News

MediSieve Announces Positive Final Results from Phase 1 Clinical Trial of its Magnetic Blood Filtration Platform
December 07, 2022

Magnetic Blood Filtration Platform shown to be safe and well tolerated, with no serious adverse events. Investigators recommend further development of the Platform, which has a range of potential clinical applications in inflammation, oncology, gene therapies and others. ...

MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study
July 08, 2022

Radboud University Medical Center is Conducting Safety Evaluation of MediSieve’s Magnetic Haemofiltration System for the Treatment of Acute Hyperinflammation.